好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Encephalitis and Risk of Epilepsy
Epilepsy/Clinical Neurophysiology (EEG)
P12 - Poster Session 12 (5:30 PM-6:30 PM)
9-006
To evaluate the risk of epilepsy versus acute symptomatic seizure in patients presenting with auto-immune or infectious encephalitis.
Seizure remains one of the common manifestations of encephalitis. Seizures occur in around 40% of cases. Both infectious and autoimmune encephalitis may cause epilepsy in some patients. Therefore, it is important to understand causes and risks of conversion from acute symptomatic seizures to epilepsy.

In this retrospective study, we searched our medical record system for patients discharged with diagnosis of encephalitis  from hospital, years 2005-2020 (N=350). Then all patients with a history of seizure at presentation or during admission  were identified (N=114). Their clinical and EEG features were extracted. We followed them in outpatient EMR to recognize the ones diagnosed with auto-immune epilepsy vs acute symptomatic epilepsy.

Seventy eight patients had an EEG during admission, 44.8% being longterm continuous EEG. In five patients, status epilepticus was captured on EEG.  23.6% of patients had auto-immune related seizures proven by antibodies or biopsy, while 43.8% of cases were infectious. On follow up, only 29 had follow up in our medical records, 15 of which were diagnosed with immune-related epilepsy. The most common cause of epilepsy in this group of patients was autoimmune (p<0.05) with NMDAR antibody being the most frequent type.

Seizure remains one of the common manifestations of encephalitis. Seizures occur in around 40% of cases

In our study, clinical outcome of epilepsy was mainly encountered among patients with auto-immune encephalitis than infectious. Moreover, contrary to prior studies, NMDAR was the most common cause of auto-immune related epilepsy. We would like to emphasize on  the importance of longterm follow up of patients with autoimmune seizures in clinic. Given the large number of lost to follow up patients, presence of multidisciplinary clinics would be helpful for providing better patient care.

Authors/Disclosures
Shirin Jamal Omidi, MD (Mayo Clinic)
PRESENTER
Dr. Jamal Omidi has nothing to disclose.
Katherine M. Harris, MD Dr. Harris has nothing to disclose.
Rodrigo Hasbun Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux.